Neurogene stops Batten gene therapy after FDA denies request, dealing double dose of bad news Read more 

Incyte's $750M buyout rocked by pause on key trial, asset cull Read more 

Nearing potential FDA approval, BridgeBio shows additional positive data on ATTR-CM candidate acoramidis Read more 

Basel

The Festival of Biologics Basel

The Festival of Biologics Basel stands as Europe's largest and most comprehensive biologics event, uniting 3000+ global attendees from antibody therapies, cell and gene therapies, [...]

Go to Top